Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,212 total articles
StoneX Group Inc. has formed a strategic partnership with The Pathfinder Group to integrate StoneX's institutional-grade cross-border payment infrastructure with Pathfinder's WITS™ platform. This collaboration aims to provide financial institutions, including community banks and credit unions, with access to improved global payment capabilities, be…
IperionX Limited has reported recent changes in the ownership stakes of its directors and officers, filing the information with both the U.S. Securities and Exchange Commission and the Australian Securities Exchange. Key executives, including the CEO and President, have acquired additional shares and American Depositary Shares, reflecting internal …
KANZHUN LIMITED, known as BOSS Zhipin, announced it has repurchased over RMB540 million worth of shares so far in 2026, including a recent purchase of RMB34.5 million on March 27. This substantial share repurchase program highlights the company's commitment to enhancing shareholder value.
Autozi Internet Technology (Global) Ltd. announced that it received a notification from Nasdaq for failing to meet the minimum Market Value of Listed Securities of $50 million over the past 30 consecutive business days. The company has until September 21, 2026, to regain compliance or face potential delisting. The notification does not impact curre…
MoonLake Immunotherapeutics reported Week 40 results from its Phase 3 VELA clinical trials evaluating sonelokimab in adults with moderate-to-severe hidradenitis suppurativa (HS). The data demonstrated continued improvement with 62% of patients achieving HiSCR75 and up to 32% achieving HiSCR100 responses, alongside significant quality of life enhanc…
Kymera Therapeutics announced positive results from its BroADen Phase 1b trial of KT-621, a novel oral STAT6 degrader, in patients with moderate-to-severe atopic dermatitis. The data showed significant biological and clinical improvements with a favorable safety profile. Ongoing Phase 2b trials in atopic dermatitis and asthma are expected to provid…
Arcutis Biotherapeutics announced new positive Phase 2 results from the INTEGUMENT-INFANT trial showing that ZORYVE (roflumilast) cream 0.05% is effective and well tolerated in infants aged 3 months to less than 24 months with mild to moderate atopic dermatitis. Caregivers reported rapid itch improvement and multiple clinical endpoints demonstrated…
Osisko Development Corp. announced its financial and operational results for Q4 and full-year 2025, highlighting approximately CAD 422.3 million in cash, sales of nearly 4,000 ounces of gold from small-scale activities at the Tintic Project, and significant advancement in the Cariboo Gold Project's infill drilling and pre-construction activities. T…
Rocket Lab successfully launched its 85th mission, marking the first dedicated launch for the European Space Agency (ESA) using its Electron launch vehicle. The 'Daughter Of The Stars' mission delivered ESA's Celeste satellites to low Earth orbit to demonstrate enhanced satellite navigation alongside Europe's Galileo constellation. This success und…
Alumis Inc. reported positive Phase 3 results for envudeucitinib, its oral TYK2 inhibitor, demonstrating robust skin clearance, rapid improvements in quality of life and itch relief, and a favorable safety profile in patients with moderate-to-severe plaque psoriasis. Data from two pivotal trials ONWARD1 and ONWARD2 indicate sustained efficacy throu…
Priovant Therapeutics, a Roivant company, reported positive Phase 3 trial results for brepocitinib in dermatomyositis, showing statistically significant improvements over placebo in multiple efficacy endpoints including muscle strength, skin disease, physical function, and corticosteroid reduction. Results were published in the New England Journal …
Biogen announced positive Phase 2 results from the AMETHYST study for litifilimab, an investigational monoclonal antibody targeting BDCA2, demonstrating statistically significant improvement in skin disease activity in patients with cutaneous lupus erythematosus (CLE). These consistent positive results, along with a favorable safety profile and FDA…
Fusion Fuel Green PLC announced details on its anticipated 2% Net Smelter Return (NSR) royalty on two mineral claims within the Shea Creek Joint Venture, part of a 16-uranium-royalty portfolio expected to be acquired through its pending transaction with Royal Uranium Inc. The Shea Creek project hosts significant undeveloped uranium resources in Can…
CNH Industrial's Case IH brand showcased its iconic Heartland Magnum tractor on the White House South Lawn during a presidential event celebrating American agriculture. This one-of-a-kind patriotic tractor symbolizes nearly four decades of manufacturing excellence and CNH's strong commitment to US farming and innovation. CNH Industrial, with a larg…
Magna International Inc., a leading global automotive supplier, has published its 2025 Annual Report, including financial statements and management analysis. The company announced its 2026 Annual Meeting of shareholders will be held virtually on May 4, 2026. Magna's reports are accessible on their website and regulatory agencies in Canada and the U…
Electra Battery Materials Corporation announced a successful recapitalization and the restart of construction on its cobalt sulfate refinery in Ontario, with a $73 million board-approved budget targeting mechanical completion in mid-2027 and commercial production by late 2027. The company strengthened its balance sheet via debt-to-equity conversion…
Manhattan Bridge Capital, Inc., a Nasdaq-listed firm specializing in short-term secured real estate loans, reported net income of approximately $5.11 million for 2025, down 8.6% from 2024 due to lower interest income and a decrease in loan originations. Revenue declined by 10.6% reflecting a contraction in loans receivable and slowed loan originati…
Biodexa Pharmaceuticals PLC, a NASDAQ-listed clinical-stage biopharmaceutical company specializing in gastrointestinal cancers, announced its audited preliminary results for the year ended December 31, 2025. Key developments include progress in the Phase 3 Serenta trial of eRapa for Familial Adenomatous Polyposis, initiation of a Phase 2a study of …
TRG Latin America Acquisitions Corp. announced that its IPO underwriter exercised part of its over-allotment option, purchasing an additional 632,000 units at $10 each. This raises the total units sold to 20,632,000 and gross proceeds to over $206 million, strengthening the company's capital for future business combinations.
Entera Bio reported full year 2025 financial results and significant business updates, highlighting progress in its oral peptide pipeline. The company submitted a streamlined Phase 3 protocol for EB613, its first oral anabolic tablet for osteoporosis, potentially accelerating approval timeline. Collaborations for other oral peptide candidates targe…
SPAR Group, Inc., a merchandising and marketing services provider in the US and Canada, announced it will release its fourth quarter and full fiscal year 2025 financial results on March 31, 2026, before the market opens. The company will host a conference call featuring its CEO and CFO to discuss the results and answer investor questions.
E-Power Inc. has announced a strategic alliance with Raytel Electronics to co-develop and launch next-generation 800G and 1.6T high-speed optical modules targeted at the North American AI data center market. By integrating Raytel's optical tech with E-Power's power solutions, the companies aim to deliver optimized connectivity and energy management…
The Atlanta Braves and Gray Media have entered a multi-year agreement to simulcast 25 regular season Braves games on Gray's local television stations across the Southeast, expanding access to free over-the-air broadcasts alongside the Braves' own BravesVision platform. Gray's Raycom Sports will provide production services for BravesVision games. Th…
VisionSys AI Inc., a NASDAQ-listed company specializing in brain-machine interaction technologies, announced a registered direct offering of 3 million American Depositary Shares (ADS) priced at $1.00 per share, aiming to raise approximately $3 million before fees. The offering is subject to customary closing conditions and is expected to close arou…
VEON Ltd. highlights strong alignment between management and shareholders through meaningful insider ownership exceeding 1.8% and ongoing disciplined capital allocation, including a substantial $100 million annual share buyback target. The company continues to execute its digital operator strategy across five frontier markets, focusing on sustainab…
